Tivic Health Systems (TIVC)
(Delayed Data from NSDQ)
$0.51 USD
-0.15 (-22.68%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $0.51 0.00 (-0.31%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
TIVC 0.51 -0.15(-22.68%)
Will TIVC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TIVC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TIVC
Tivic Health Systems, Inc. (TIVC) Reports Q3 Loss, Misses Revenue Estimates
Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates
TIVC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Senseonics Holdings (SENS) Reports Q2 Loss, Misses Revenue Estimates
Azenta (AZTA) Beats Q3 Earnings and Revenue Estimates
CareCloud, Inc. (CCLD) Reports Q2 Loss, Lags Revenue Estimates
Other News for TIVC
Tivic Announces 2024 Annual Meeting of Stockholders
Tivic Health Ends Agreement with ALOM to Reduce Costs
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Why AMD Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
TLRY Stock: Tilray’s Aphria RX Receives Cannabis Trading License in Germany